Overview

Efficacy and Tolerability of an Intra-Nasal Testosterone Product

Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
This clinical trial is being performed to compare the pharmacokinetic profile of testosterone after repeated intra-nasal administration of products of different strengths in subjects with hypogonadism.
Phase:
Phase 2
Details
Lead Sponsor:
Acerus Pharmaceuticals Corporation
Trimel Biopharma SRL
Treatments:
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate